{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:49:04Z","timestamp":1773866944896,"version":"3.50.1"},"reference-count":1,"publisher":"Polish Academy of Sciences Chancellery","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Retinal complications in diabetes are a leading cause of vision loss in adults. Long-term hyperglycemia triggers molecular changes that damage retinal neuronal tissues and blood vessels, leading to degeneration, inflammation, and vision impairment. Studies show that the Receptor for Advanced Glycation End-Products (RAGE) and its cytosolic ligand, Diaph1 are both implicated in the pathogenesis of diabetic complications; however, their role in the development of retinal damage is not yet clear. We hypothesized that the deletion of either RAGE or Diaph1 would be beneficial and prevent or delay damage to the retinal structure in diabetes. Wild-type, RAGE and Diaph1 knockout mice were used in the study. The mice were randomly selected and divided into control and diabetic groups. Diabetes was induced with Streptozotocin injections, and six months after diabetes induction all mice were sacrificed, samples collected and processed for morphometric analysis. Our analysis revealed a reduction in retinal depth across all layers between control and diabetic samples. The effect of RAGE or Diaph1 deletion on retinal structure differed, indicating that both proteins may play independent if not interchangeable roles in retina function and structure, highlighting their potential role in the pathogenesis of diabetic retinal complications.<\/jats:p>","DOI":"10.24425\/pjvs.2026.158507","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:05:32Z","timestamp":1773839132000},"page":"127-127","source":"Crossref","is-referenced-by-count":0,"title":["RAGE and Diaph1 deficiency affect retinal cytoarchitecture both in physiological and long-term hyperglycemic settings in diabetic mice \u2013 a preliminary study"],"prefix":"10.24425","author":[{"given":"P.","family":"Mizia","sequence":"first","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-085, Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kordas","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-085, Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Mazur","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-085, Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jaros\u0142awska-Miszkiewicz","sequence":"additional","affiliation":[{"name":"Department of Biological Functions of Food, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, W\u0142adys\u0142awa Tryli\u0144skiego 18, 10-683 Olsztyn Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Szyry\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-713 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"W\u0105sowicz","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Forensic and Administration of Veterinary Medicine, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-713, Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Juranek","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-085, Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37468","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"ref0","unstructured":"Cheung N, Mitchell P and Wong TY (2010) Diabetic retinopathy. Lancet 3769735: 124-136. Daffu G, Shen X, Senatus L, Thiagarajan D, Abedini A, Hurtado Del Pozo C, Rosario R, Song F, Friedman RA, Ramasamy R and Schmidt AM (2015) RAGE Suppresses ABCG1Mediated Macrophage Cholesterol Efflux in Diabetes. Diabetes 6412: 4046-4060. Dong H, Zhang Y, Huang Y and Deng H (2022) Pathophysiology of RAGE in inflammatory diseases. Front Immunol 13: 931473. Juranek JK, Aleshin A, Rattigan EM, Johnson L, Qu W, Song F, Ananthakrishnan R, Quadri N, Yan SD, Ramasamy R, Schmidt AM and Geddis MS (2010) Morphological Changes and Immunohistochemical Expression of RAGE and its Ligands in the Sciatic Nerve of Hyperglycemic Pig (Sus Scrofa). Biochem Insights 20103: 47-59. Juranek JK, Geddis MS, Rosario R and Schmidt AM (2013) Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE. Eur J Neurosci 388: 3159-3168. Juranek JK, Geddis MS, Song F, Zhang J, Garcia J, Rosario R, Yan SF, Brannagan TH and Schmidt AM (2013) RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 623: 931-943. Kumari N, Karmakar A, Chakrabarti S and Ganesan SK (2020) Integrative Computational Approach Revealed Crucial Genes Associated With Different Stages of Diabetic Retinopathy. Front Genet 11: 576442. Lee JH, Park JH, Nam TW, Seo SM, Kim JY, Lee HK, Han JH, Park SY, Choi YK and Lee HW (2018) Differences between immunodeficient mice generated by classical gene targeting and CRISPR\/Cas9-mediated gene knockout. Transgenic research 273: 241-251. Lu Q, Lu L, Chen W, Chen H, Xu X and Zheng Z (2015) RhoA\/mDia-1\/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2535: 669-680. Lu Q, Lu P, Chen W, Lu L and Zheng Z (2018) ANGPTL-4 induces diabetic retinal inflammation by activating Profilin-1. Exp Eye Res 166: 140-150. Lu Z, Fan B, Li Y and Zhang Y (2023) RAGE plays key role in diabetic retinopathy: a review. Biomed Eng Online 221: 128. Mao Y (2011) FORMIN a link between kinetochores and microtubule ends. Trends Cell Biol 2111: 625-629. Palander O and Trimble WS (2020) DIAPH1 regulates ciliogenesis and trafficking in primary cilia. FASEB J 3412: 16516-16535. Rai V, Maldonado AY, Burz DS, Reverdatto S, Yan SF, Schmidt AM and Shekhtman A (2012) Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J Biol Chem 2877: 5133-5144. Schmidt AM, Hofmann M, Taguchi A, Yan SD and Stern DM (2000) RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Seminars in thrombosis and hemostasis 265: 485-493. Sharma A, Valle M L, Beveridge C, Liu Y and Sharma S (2019) Unraveling the role of genetics in the pathogenesis of diabetic retinopathy. Eye (Lond) 334: 534-541. Takagi H (2003) Molecular mechanisms of retinal neovascularization in diabetic retinopathy. Intern Med 423: 299-301. Wang Y, Vom Hagen F, Pfister F, Bierhaus A, Feng Y, Gans R and Hammes H P (2008) Receptor for advanced glycation end product expression in experimental diabetic retinopathy. Annals of the New York Academy of Sciences 1126: 42-45."}],"container-title":["Polish Journal of Veterinary Sciences"],"original-title":[],"language":"pl","link":[{"URL":"https:\/\/journals.pan.pl\/Content\/138537\/14%20_%20Mizia%20_%20Short.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:26:59Z","timestamp":1773840419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.pan.pl\/dlibra\/publication\/158507\/edition\/138537\/content"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":1,"URL":"https:\/\/doi.org\/10.24425\/pjvs.2026.158507","relation":{},"ISSN":["1505-1773"],"issn-type":[{"value":"1505-1773","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}